FDA Approves New Bivalent COVID-19 Booster for Use in Children
Moderna vaccine is authorized for children down to 6 years old, while Pfizer-BioNTech vaccine is approved for children as young as 5 years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.